Henry Schein (NASDAQ:HSIC) Releases FY 2025 Earnings Guidance

Key Points

• Henry Schein updated its FY 2025 earnings guidance, projecting EPS between $4.800-$4.940, slightly above the consensus estimate of $4.876, and revenue guidance of $12.4 billion-$13.2 billion, compared to an estimate of $13.0 billion.
• The company's stock fell 8.1% during trading, reaching $64.35, following its earnings report that showed an EPS miss of $1.10 versus a consensus estimate of $1.19.
• Analyst ratings have shifted, with several firms downgrading Henry Schein, resulting in a consensus rating of "Hold" and an average target price of $78.08.

Henry Schein (NASDAQ:HSIC - Get Free Report) updated its FY 2025 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 4.800-4.940 for the period, compared to the consensus estimate of 4.876. The company issued revenue guidance of $12.4 billion-$13.2 billion, compared to the consensus revenue estimate of $13.0 billion.

Analyst Ratings Changes

Several research firms have recently weighed in on HSIC. Wall Street Zen lowered Henry Schein from a "buy" rating to a "hold" rating in a research report on Thursday, April 17th. Baird R W lowered Henry Schein from a "strong-buy" rating to a "hold" rating in a research report on Monday, July 14th. Piper Sandler reduced their target price on Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a research note on Wednesday, April 30th. Stifel Nicolaus restated a "hold" rating and issued a $75.00 target price (down from $80.00) on shares of Henry Schein in a research note on Friday, July 25th. Finally, Barrington Research reduced their target price on Henry Schein from $90.00 to $86.00 and set an "outperform" rating for the company in a research note on Tuesday, May 6th. Nine equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $78.08.

Henry Schein Stock Down 8.1%

HSIC stock traded down $5.67 during mid-day trading on Tuesday, reaching $64.35. 2,962,837 shares of the company traded hands, compared to its average volume of 1,736,743. Henry Schein has a fifty-two week low of $60.56 and a fifty-two week high of $82.49. The firm's 50 day moving average price is $71.58 and its 200 day moving average price is $71.30. The company has a quick ratio of 0.75, a current ratio of 1.38 and a debt-to-equity ratio of 0.50. The stock has a market cap of $7.83 billion, a price-to-earnings ratio of 20.11, a P/E/G ratio of 2.20 and a beta of 0.81.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.09). Henry Schein had a return on equity of 14.87% and a net margin of 3.21%. The firm had revenue of $3.24 billion for the quarter, compared to the consensus estimate of $3.22 billion. During the same period in the prior year, the business earned $1.23 EPS. Henry Schein's quarterly revenue was up 3.3% compared to the same quarter last year. As a group, equities research analysts predict that Henry Schein will post 4.74 EPS for the current fiscal year.

Institutional Investors Weigh In On Henry Schein

A number of hedge funds have recently modified their holdings of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in Henry Schein by 1.4% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 16,859 shares of the company's stock valued at $1,155,000 after acquiring an additional 229 shares during the period. AQR Capital Management LLC raised its holdings in Henry Schein by 47.3% during the 1st quarter. AQR Capital Management LLC now owns 30,402 shares of the company's stock valued at $2,071,000 after acquiring an additional 9,756 shares during the period. Finally, Acadian Asset Management LLC bought a new stake in Henry Schein during the 1st quarter valued at $676,000. Institutional investors own 96.62% of the company's stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.